MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 181 to 200 of 166,322 approvalsPage 10 of 8317

Iguratimod Tablets

Approval Number: 国药准字H20254383
Registration: May 27, 2025

Avatrombopag Maleate tablet

Approval Number: 国药准字H20254261
Registration: May 27, 2025

Polyethylene Glycol(3350)and Electrolytes Powder

Approval Number: 国药准字H20254388
Registration: May 27, 2025

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number: 国药准字H20254275
Registration: May 27, 2025

Tadalafil Tablets

Approval Number: 国药准字H20254357
Registration: May 27, 2025

Voriconazole for Oral Suspension

Approval Number: 国药准字H20254249
Registration: May 27, 2025

Ibuprofen Granules

Approval Number: 国药准字H20254259
Registration: May 27, 2025

Bisoprolol Fumarate and Amlodipine Besilate Tablets

Approval Number: 国药准字H20254304
Registration: May 27, 2025

Gliclazide Sustained-release Tablets

Approval Number: 国药准字H20254382
Registration: May 27, 2025

Mirtazapine Tablets

Approval Number: 国药准字H20254248
Registration: May 27, 2025

Ibuprofen Suspension Drops

Approval Number: 国药准字H20254258
Registration: May 27, 2025

Cobamamide Capsules

Approval Number: 国药准字H20254385
Registration: May 27, 2025

Ceftizoxime Sodium for Injection

Approval Number: 国药准字H20254298
Registration: May 27, 2025

Ceftizoxime Sodium for Injection

Approval Number: 国药准字H20254291
Registration: May 27, 2025

Tofacitinib Citrate Tablets

Approval Number: 国药准字H20254279
Registration: May 27, 2025

Ceftizoxime Sodium for Injection

Approval Number: 国药准字H20254292
Registration: May 27, 2025

Bromhexine Hydrochloride Oral Solution

Approval Number: 国药准字H20254393
Registration: May 27, 2025

Nimodipine Injection

Approval Number: 国药准字H20254269
Registration: May 27, 2025

Levofloxacin and Sodium Chloride Injection

Approval Number: 国药准字H20254335
Registration: May 27, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.